Ruijing Bio

Shanghai, China · Founded 2017 · Privately Held (backing)

Developer of molecular diagnosis technology designed for precision cancer medicine. Ruijing Bio is based in Shanghai, China and was founded in 2017. Its last reported valuation was $109 million in Apr 2022. It has raised $44 million.

Last reported valuation
$109.1M
Oct 2026
Priced at
—
Total raised
$44.0M
Last round
—

Who backs Ruijing Bio?

7 investors
InvestorType
ZhenFundOther
Guotai Junan Innovation InvestmentVenture capital
Shenzhen Yifeng Investment Management EnterpriseVenture capital
Prosperico VenturesOther
Rencent CapitalOther
BioTrack Capital—
Shenzhen Jinsheng Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ruijing Bio investors

Free account
More of Ruijing Bio with a free account
  • ·Watch Ruijing Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Ruijing Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View